Ingevity Corp Files 8-K for Operations Update

TL;DR

Ingevity filed an 8-K on Jan 16, 2025, for operations and Reg FD. Details TBD.

AI Summary

Ingevity Corporation filed an 8-K on January 16, 2025, to report on its results of operations and financial condition, as well as to provide a Regulation FD disclosure. The filing does not contain specific financial figures or details about the nature of the disclosure.

Why It Matters

This filing indicates Ingevity is providing an update on its financial performance and potentially material information to the public, which is important for investors to monitor.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for operational and financial condition updates, not indicating immediate significant risk.

Key Players & Entities

• Ingevity Corporation (company) — Registrant
• 0001653477 (company) — Central Index Key
• 20250116 (date) — Filing Date

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common Stock ($0.01 par value) NGVT New York Stock Exchange

Filing Documents

• ngvt-20250116.htm (8-K) — 34KB
• exhibit99111525.htm (EX-99.1) — 21KB
• image1.jpg (GRAPHIC) — 143KB
• ngvt-20250116_g1.jpg (GRAPHIC) — 143KB
• 0001653477-25-000005.txt ( ) — 673KB
• ngvt-20250116.xsd (EX-101.SCH) — 2KB
• ngvt-20250116_lab.xml (EX-101.LAB) — 21KB
• ngvt-20250116_pre.xml (EX-101.PRE) — 12KB
• ngvt-20250116_htm.xml (XML) — 3KB

02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 16, 2025, Ingevity Corporation ("Ingevity" or the "Company") issued a press release (the "Press Release") announcing, among other things, certain unaudited preliminary financial results for the Company's fiscal year 2024. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The preliminary financial results provided in the Press Release remain subject to completion of the Company's fiscal year financial audit.

01. REGULATION FD DISCLOSURE

ITEM 7.01. REGULATION FD DISCLOSURE The Press Release also announced that Ingevity is exploring strategic alternatives for the Company's Performance Chemicals Industrial Specialties product line, including a potential divestiture of portions of its North Charleston site. The information provided in Item 2.02 and Item 7.01 of this Current Report on Form 8-K, including the Press Release attached hereto as Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains "forward looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words "will," "plans," "intends," "targets," "expects," "outlook," "guidance," "believes," "anticipates" or similar expressions. Forward looking statements may include, without limitation, anticipated timing, results, charges and costs of any current or future repositioning of our Performance Chemicals segment, including the announced review of strategic alternatives for the Industrial Specialties product line and North Charleston, South Carolina crude tall oil refinery, the oleo-based product refining transition and closure of our plants in Crossett, Arkansas and DeRidder, Louisiana; leadership transitions within our organization; the potential benefits of any acquisition or investment transaction, expected financial positions, guidance, results of operations and cash flows; financing plans; business strategies and expectations; operating plans; capital and other expenditures; competitive positions; growth opportunities for existing products; benefits from new technology and cost reduction initiatives, plans and objectives; litigation-related strategies and outcomes; and markets for securities. Actual results could differ materially from the views expressed. Factors that could cause actual results to materially differ from those contained in the forward looking statements, or that could cause other forward looking statements to prove incorrect, include, without limitation, charges, costs or actions, including adverse legal or regulatory actions, resulting from, or in connection with, the current or future repositioning of our Performance Chemicals segment, including the announced review of strategic alternatives for the Industrial Specialties product line and North Charleston, South Carolina crude tall o

01. FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Press release dated January 16, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INGEVITY CORPORATION (Registrant) By: /S/ MARY DEAN HALL Mary Dean Hall Executive Vice Presidentand Chief Financial Officer Date: January 16, 2025